Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dry Macular Degeneration”

286 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 286 results

Testing effectiveness (Phase 2)Ended earlyNCT02087085
What this trial is testing

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyMacular Degeneration
Allergan 310
Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Not applicableEnded earlyNCT03935126
What this trial is testing

Global Atrophie Biomarker Evaluation Study (GABiE)

Who this might be right for
Age-related Macular Degeneration
Boehringer Ingelheim 3
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Not applicableStudy completedNCT04349254
What this trial is testing

Observational Study of Vision Improvement in Late Stage Dry AMD Patients

Who this might be right for
Dry Age-related Macular Degeneration
Optimal Acuity Corporation 17
Testing effectiveness (Phase 2)Study completedNCT02613572
What this trial is testing

Alpha Lipoic Acid in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
University of Pennsylvania 68
Not applicableStudy completedNCT02464956
What this trial is testing

Production of iPSC Derived RPE Cells for Transplantation in AMD

Who this might be right for
Age Related Macular Degeneration (AMD)
Moorfields Eye Hospital NHS Foundation Trust 3
Not applicableUnknownNCT03859245
What this trial is testing

Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention

Who this might be right for
Diabetic Retinopathy (DR)Age-related Macular Degeneration (AMD)Mid-peripheral Drusen Formation+1 more
Bristlecone Health, Inc. 30
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Testing effectiveness (Phase 2)UnknownNCT02590692
What this trial is testing

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Who this might be right for
Dry Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 16
Testing effectiveness (Phase 2)Ended earlyNCT01675947
What this trial is testing

Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
National Eye Institute (NEI) 52
Not applicableNot Yet RecruitingNCT05780931
What this trial is testing

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
VA Office of Research and Development 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06373731
What this trial is testing

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Who this might be right for
Age Related Macular Degeneration (ARMD)
Stealth BioTherapeutics Inc. 313
Testing effectiveness (Phase 2)Ended earlyNCT01674829
What this trial is testing

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHABiotech CO., Ltd 10
Not applicableNot Yet RecruitingNCT05418231
What this trial is testing

Observation of the Natural Course of Age-related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationMacular Degeneration, Dry
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT00935883
What this trial is testing

Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Philip J. Rosenfeld, MD, PhD 60
Load More Results